Sandoz Canada Obtains Regulatory Approval From Health Canada for (Pr)Sandoz® Semaglutide, a Generic Version of (Pr)Ozempic®

Globo

Lean Right

Factuality

Ownership

Sandoz has been authorized by Health Canada, the country's regulatory authority, to market a generic version of Ozempic, a medicine developed by Danish New for the treatment of type 2 diabetes in adult patients. It is exclusive to subscribers. To have full access, access the link of the material and register.

Portal GMC Online

Factuality

Ownership

Sandoz informed that it received approval from the Canadian regulatory authority for its generic version of Ozempic, blockbuster medicine for diabetes...

Les Affaires

Factuality

Ownership

PrSandoz® Semaglutide, a generic of PrOzempic®, is approved for the treatment of type 2 diabetes mellitus in adult patients.